Teva Pharmaceutical Industries reported $3.18B in Operating Expenses for its fiscal quarter ending in September of 2026.





Operating Expenses Change Date
Aspen Pharmacare ZAR 13.32B 5.36B Dec/2025
Cipla INR 63.61B 1.3B Sep/2026
Dr.Reddys Laboratories INR 74.82B 2.93B Sep/2026
Guangzhou Baiy CNY 19.35B 1.04B Sep/2026
Jiangsu Hengrui CNY 6.01B 449.22M Sep/2026
Kalbe Farma IDR 8.52T 128.87B Sep/2026
Richter Gedeon HUF 165.23B 7.35B Jun/2026
Sh Fosun Pharma CNY 9.09B 637.86M Sep/2026
Sun Pharmaceuticals INR 122.92B 5.49B Sep/2026
Teva Pharmaceutical Industries USD 3.18B 733M Sep/2026